Cardiovascular Medicine
Showing 1-28 of 28 Results
-
Matteo Cartura
Postdoctoral Scholar, Cardiovascular Medicine
BioMatteo Cartura is a postdoctoral researcher in cardiovascular science, focusing on the clinical association between genetic variants identified in GWAS studies and the pathophysiology of atherosclerosis. He obtained his PhD at the Institute for Vascular Signalling, with a research focus on the immunological functions of endothelial cells in atherosclerosis. He holds a Bachelor’s and Master’s degree in Biology and Biotechnology.
-
Joshua Gillard
Postdoctoral Scholar, Cardiovascular Medicine
BioDr. Josh Gillard is a Canadian biomedical data scientist with experience in bioinformatics, machine learning, and immunology. After completing a BSc and a MSc in Experimental Medicine at McGill university, he relocated to the Netherlands for his PhD in bioinformatics at Radboud University in Nijmegen. During his PhD, he gained experience analyzing and interpreting complex immunological data (bulk and single-cell transcriptomics, high-dimensional cytometry, high-throughput proteomics) derived from human observational or intervention studies (vaccination and experimental human infection). This work revealed molecular and cellular correlates of clinically important endpoints such as disease severity, symptom progression, and antibody responses. In 2022, Josh relocated to Stanford to join the Gaudilliere lab to develop and apply multi-omic data integration and machine learning techniques, establishing that early gestational immune dysregulation can predict preterm birth. Since 2024, in the Ashley lab, Josh is developing deep learning models to investigate aberrant splicing in cardiovascular disease.
-
Shreya Gupta
Postdoctoral Scholar, Cardiovascular Medicine
Current Research and Scholarly InterestsI am a biomedical researcher focused on understanding the molecular mechanisms governing vascular smooth muscle cell (SMC) behavior in cardiovascular and metabolic diseases. My work investigates how signaling pathways, including Notch3 and Thrombospondin-1, regulate SMC phenotypic switching, fibrous cap stability, and plaque vulnerability in atherosclerosis, with the goal of identifying novel therapeutic targets to prevent heart attacks and strokes.
-
Edward Guzman
Postdoctoral Scholar, Cardiovascular Medicine
BioEdward Guzman is a postdoctoral fellow in cardiovascular medicine at Stanford University. He earned his Ph.D. from Harvard University in collaboration with the Massachusetts Institute of Technology (MIT), focusing on RNA treatments for vascular diseases. His research has advanced the development of novel cardiovascular therapies and deepened our understanding of endothelial cell biology under diseased conditions.
-
Jiaqi Hu
Postdoctoral Scholar, Cardiovascular Medicine
BioJiaqi Hu is a Postdoctoral Scholar at Stanford University, supervised by Drs. Tim Assimes and Shoa Clarke. She received her PhD in Chronic Disease Epidemiology from the Yale School of Public Health in 2026 and her Bachelor of Arts degree from Peking University in 2021. Her research focuses on identifying genetic variants underlying complex diseases, applying polygenic scores for disease risk prediction and subtype identification, and integrating genetic, environmental, and clinical data to improve individual-level risk stratification.
-
Hirotaka Ieki
Postdoctoral Scholar, Cardiovascular Medicine
BioI am an MD, PhD physician-scientist aiming to advance precision medicine for cardiovascular disease through research in genomics and artificial intelligence.
MD, The University of Tokyo, Tokyo, 2013
Residency in Internal Medicine, National Center for Global Health and Medicine, Tokyo, 2013-2017
Residency in Cardiology, Sakakibara Heart Institute, Tokyo, 2015–2017
PhD, The University of Tokyo, Tokyo, 2021
Clinical Fellow in Cardiology, The University of Tokyo Hospital, Tokyo, 2021–2022
Postdoctoral Scholar, Stanford University, 2023–present
Research interest: Precision medicine in cardiovascular disease. Genomics, Artificial Intelligence -
Samuel Montalvo
Postdoctoral Scholar, Cardiovascular Medicine
BioAs a clinical exercise physiologist, sport scientist, and biomechanist, I study the mechanical, physiological, and molecular determinants of human performance and health. I am certified as a Performance and Sport Scientist (CPSS), Strength and Conditioning Specialist with Distinction (CSCS,*D), and Clinical Exercise Physiologist.
I am a Postdoctoral Scholar in Cardiovascular Medicine at Stanford University and a member of the Stanford Bioinformatics Core and Wu Tsai Human Performance Alliance. My training has been supported by the Wu Tsai Human Performance Alliance Postdoctoral Fellowship, the NIH T32 Research Training in Myocardial Biology at Stanford, and a two-year NIH/NHLBI Loan Repayment Program award in Research in Emerging Areas Critical to Human Health.
My research integrates clinical exercise physiology, cardiopulmonary exercise testing, biomechanics, and multi-omics to better understand how physical activity influences cardiovascular health, biological adaptation, and athletic performance. Through the NIH-funded Molecular Transducers of Physical Activity Consortium, I analyze large clinical, multi-omic, multi-tissue, multi-modality, and multi-species datasets to identify mechanisms and biomarkers of exercise response.
I also collaborate on projects involving sports cardiology and electrocardiography, cardiopulmonary exercise testing, exercise and neuromuscular disease, and athlete performance, including work with Stanford Baseball and external sports-science collaborators.
Teaching and mentoring are central to my academic work. As a first-generation college graduate and Mexican American with Indigenous heritage, I am committed to creating supportive and inclusive pathways for trainees from underrepresented backgrounds. I serve as a Postdoctoral Mentoring Coach with the Stanford Office of Postdoctoral Affairs, participate in the Stanford PRISM program, and mentor prospective and current medical students through the MAVERICs program within the Stanford Cardiovascular Institute.
My long-term goal is to lead an independent research program that combines exercise physiology, multi-omics, physical activity, nutrition, cardiovascular science, and sports performance while mentoring the next generation of scientists. -
Andrew Thai Nguyen
Clinical Scholar, Medicine - Cardiovascular Medicine
Postdoctoral Scholar, Cardiovascular MedicineBioDr. Andrew Nguyen is a Cardiologist and a Clinical Scholar in the Department of Medicine, Division of Cardiovascular Medicine. He earned his medical degree from Harvard Medical School in the Harvard-MIT Health Sciences and Technology Program. He then completed his residency in Internal Medicine at Stanford University, followed by fellowship training in Cardiovascular Medicine also at Stanford University.
As a non-invasive cardiologist, Dr. Nguyen cares for patients undergoing cancer therapy as well as cancer survivors in the Stanford Health Care Cardio-Oncology Program. He provides evidenced-based cardiovascular care for patients throughout their cancer journey while managing and preventing treatment toxicities. Dr. Nguyen is a physician scientist who is mentored by Dr. Paul Cheng and Dr. Tom Quertermous. His research blends his clinical interest in cardio-oncology with basic science to understand the complex interplay between cancer angiogenesis and ischemic heart disease. He is a recipient of the AHA Postdoctoral Fellowship Award, ACC/Merck Research Fellowship Award, and NIH F32 Award. -
Connor Galen O'Brien
Postdoctoral Medical Fellow, Cardiovascular Medicine
BioDr. O'Brien is a native of Menlo Park, CA. He attended medical school at Columbia University College of Physicians and Surgeons. At Columbia he was elected to both Alpha Omega Alpha and Gold Humanism Honors Societies. He completed an Internal Medicine residency as well as fellowship in Cardiovascular Medicine at Stanford University. In his third year of fellowship, he was selected Chief Cardiology Fellow.
He is currently a post-doctoral fellow performing regenerative medicine research, specifically studying the role of exosomes in treating cardiomyopathy. In addition to his basic science research, he is also involved in human clinical trials investigating the role of stem cells in treating various forms of cardiomyopathy. -
Laurens van de Wiel
Postdoctoral Scholar, Cardiovascular Medicine
BioI am a post-doctoral researcher at Stanford University under supervision of Matthew Wheeler and Stephen Montgomery. My research focuses on understanding the entire spectrum of genetic variation effects on protein function and structure in order to decipher molecular mechanisms of disease.
My post-doctoral work centers on developing novel software methodologies which combine multi-omics data to interpret the functional impact of genetic variants in undiagnosed patients. I am part of the Undiagnosed Disease Network (UDN) at Stanford Center for Undiagnosed Diseases (CUD), Genomics Research to Elucidate the Genetics of Rare Diseases (GREGoR) consortium at GREGoR Stanford Site (GSS), and the Molecular Transducers of Physical Activity Consortium (MoTrPAC) at the Bioinformatics Center (BIC).
Before joining Stanford. I was received my Ph.D. in 2021 at the Radboud University Medical Center under supervision of Christian Gilissen, Gert Vriend, and Joris Veltman. I received my MSc degree in 2014 at Radboud University under supervision of Tom Heskes, Evgeni Levin, and Armand Paauw. Before my Ph.D, I worked as a Data Scientist at FLXone, where I developed machine learning solutions within a large-scale, real-time infrastructure.
Research
I am interested in a variety of topics in Bioinformatics and Computer Science. In particular, I am interested in the application of Artificial Intelligence and Statistical Modelling to analyse human (Rare) Mendelian Disease Genetics, Evolutionary Comparative Genomics, Protein Domain Homology, and Molecular Structures. -
Yunyun Wang
Postdoctoral Scholar, Cardiovascular Medicine
BioYunyun is a postdoctoral scholar in Cardiovascular Medicine at Stanford. She received her PhD in Genetics from Zhejiang University in China (2025), where she studied the metabolic-epigenetic mechanisms of cardiovascular disease such as atherosclerosis and angiogenesis. In 2026, she joined the Quertermous Lab, where her research focuses on uncovering the mechanisms underlying atherosclerosis using Perturb-seq technology.
